• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENASEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENASEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-403
Device Problem Biocompatibility (2886)
Patient Problems Erythema (1840); Itching Sensation (1943); Local Reaction (2035)
Event Date 02/16/2024
Event Type  Injury  
Manufacturer Narrative
Image analysis 3 film images were returned for review.Image 1: ¿image received of a patient¿s leg seemingly with a rash/adverse reaction present, consistent with the reported event.Lot number # of the device could not be confirmed based on the returned image.¿.Image 2: ¿image received of a patient¿s leg seemingly with a rash/adverse reaction present, consistent with the reported event.Lot number # of the device could not be confirmed based on the returned image.¿.Image 3: ¿image received of a patient¿s leg seemingly with a rash/adverse reaction present, consistent with the reported event.Lot number # of the device could not be confirmed based on the returned image.¿.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A physician used a venaseal closure system to treat vascular reflux in a patient¿s great saphenous vein (gsv).Little vessel tortuosity was reported.The lumen was not flushed prior to use.The ifu (instruction for use) was followed during preparation, procedure, post-procedure.A guidewire was used during catheter insertion and placement.The catheter tip was 5cm caudal to sfj.Tumescent infiltration was not utilized.Local anesthesia was used.No compression was used.The procedure was completed as usual and the vein was reported to have closed.Approximately 3 months post procedure the patient went to the hospital due to delayed allergy.Symptoms were itching with reddening along the glue injection site.Patient was prescribed with prednisone 5 mg/day and locoid cream.Both legs were treated but the reaction was present in only one leg.It was reported that the glue may be in the blood vessels outside the compartment.The patient's complaints disappeared, but the redness remained.The patient visited the hospital for follow up approximately 1 week later, the appearance had not changed but the symptoms had improved.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENASEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18918936
MDR Text Key337844261
Report Number9612164-2024-01297
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/16/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-403
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/19/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-